The effect of apremilast on epicardial adipose tissue in psoriasis

This publication has 10 references indexed in Scilit:

• Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
  Nature Reviews Cardiology, 2024
• Cardiovascular Health in People with Psoriasis: A Population-Based Study in the United States
  Journal of Investigative Dermatology, 2023
• Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis
  JAMA Dermatology, 2022
• Epicardial adipose tissue in contemporary cardiology
  Nature Reviews Cardiology, 2022
• Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
  Journal of Investigative Dermatology, 2021
• Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study
  Rheumatology, 2021
• Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
  JACC: Heart Failure, 2021
• Quantification of epicardial fat using non contrast cardiac CT in an HIV population: Reproducibility and association with other body fat indices
  European Journal of Radiology Open, 2021
• Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time
  JCI Insight, 2020
• Liraglutide causes large and rapid epicardial fat reduction
  Obesity, 2017